Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nanobiotix S.A
NBTX | US
40.13
USD6.14
18.06%
NBTX | US
Loading StockChartView...
About Nanobiotix S.A
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
40.13
Open
36.67
High
41.89
Low
36.67
Nanobiotix S.A. a clinical-stage biotechnology focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3 a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma head and neck cancers liver cancers prostate cancer pancreatic cancer esophageal cancer rectal cancer and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China South Korea Singapore and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris France.
View LessNBTX | US
Risk
122.5
Sharpe
10.39
Luna's Score
64/100
Recommendation
Hold
Luna says (NBTX | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
130.3%1 month
122.5%3 months
86.3%6 months
122.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
48.31
Price to book
65.02
Debt to equity
-2.04
Debt to assets
0.51
Ent. to EBITDA
-2.45
Ent. to rev.
5.22
PEG
-
Other Fundamentals
EBITDA
-22.30M
MarketCap
1.91B
MarketCap(USD)
1.91B
Div. yield
-
Op. margin
-253.32
Erngs. growth
-
Rev. growth
182.10
Ret. on equity
-198.69
Short ratio
2.52
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
17.40
Range1M
19.53
Range3M
22.28
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.06
Price X volume
4.09M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.45 | 0.53 | Cheaper |
| Ent. to Revenue | 5.22 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 65.02 | 15.55 | Expensive |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 86.26 | 72.80 | Par |
| Debt to Equity | -2.04 | -1.23 | Cheaper |
| Debt to Assets | 0.51 | 0.25 | Expensive |
| Market Cap | 1.91B | 3.66B | Emerging |
